Southpoint Capital Advisors LP Sanofi Transaction History

Southpoint Capital Advisors LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2018 May 15, 2018	SELL	$38.98 - $45.76 $85.8 Million - $101 Million	-2,200,000 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$42.86 - $50.61 $8.57 Million - $10.1 Million	200,000 Added 10.0%	2,200,000 $94.6 Million
Q3 2017 Nov 14, 2017	BUY	$47.04 - $50.34 $94.1 Million - $101 Million	2,000,000	2,000,000 $99.6 Million

807

270M

1.9M

Ticker SNY
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,508,100,096
Market Cap $134B
Description
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...

Get notified when there are updates to the investment portfolio of Southpoint Capital Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Southpoint Capital Advisors LP with notifications on news.